Clinical Trial Update: Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of tocilizumab in generalized myasthenia gravis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Myasthenia Gravis, Generalized | Phase 2 | Status: RECRUITING